All conventional peritoneal cavity B1 cells show D6-dependent CCL2AF647 uptake. (A) Flow cytometric fractionation of WT peritoneal cavity CD19+ cells using anti-CD11b and anti-CD5. (B) Overlaid CCL2AF647 uptake profiles of WT (black) and D6-deficient (KO; gray) peritoneal cavity CD19+ cell subsets. Bar graph shows average MFI ± SEM of CCL2AF647 uptake by each subset. (C) Overlaid flow cytometry plots of CCL2AF647 uptake by WT CD19+CD11b+ peritoneal cavity cells after incubation at 4°C (black) or at 37°C in the presence (gray) or absence (dashed) of a 10-fold excess of unlabeled CCL22. (D) Expression of D6 mRNA in FACS-sorted B-cell populations (pooled from 4 WT mice). B1a/b are CD19+CD11b+ cells. Expression by CD19+CD11b−CD5− (11b−5−) cells was set to 1. (E) Overlaid CCL2AF647 uptake profiles of WT (black) and KO (gray) peritoneal cavity T cells (CD19−CD11b−CD5hi) and macrophages (CD19−CD11b+CD5−). Flow cytometric profiles are representative of data generated from > 3 mice per genotype per experiment, with experiments repeated at least 3 times.